Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 66,650 clinical trials worldwide
Search
Showing 47201-47250 of 66,650 trials
Active filters:
Status: Recruiting
Clinical Trials (66,650)
NCT05762146
Networked Drug REpurposing for Mechanism-based neuroPrOtection in Acute Ischaemic STROKE
PHASE2
Recruiting
28 participants
Started: Sep 5, 2022 · Completed: Apr 30, 2024
1 condition
1 sponsor
1 location
NCT05318196
Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases
N/A
Recruiting
5,000 participants
Started: Sep 5, 2022 · Completed: Sep 1, 2032
6 conditions
1 sponsor
1 location
NCT05413005
Efficacy of Extracorporeal Photopheresis (ECP) in the Treatment of Type 1 Diabetes Mellitus
EARLY_PHASE1
Recruiting
10 participants
Started: Sep 5, 2022 · Completed: Dec 1, 2026
1 condition
1 sponsor
1 location
NCT05302505
Simulation-based Training for Nurses and Arteriovenous Fistula Puncture in Chronic Hemodialysis Patients
NA
Recruiting
9,600 participants
Started: Sep 5, 2022 · Completed: Sep 30, 2024
3 conditions
1 sponsor
9 locations
NCT05536102
The Effectiveness and Safety of XELOX and Tislelizumab + PLD for Resectable Gastric Cancer (LidingStudy)
PHASE2
Recruiting
38 participants
Started: Sep 5, 2022 · Completed: Sep 30, 2027
1 condition
1 sponsor
1 location
NCT06194474
Study on Biomarkers of Postoperative Delirium in Elderly Cardiac Surgery Patients
N/A
Recruiting
24 participants
Started: Sep 5, 2022 · Completed: Feb 29, 2024
1 condition
1 sponsor
1 location
NCT05481879
Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-101 in Participants With Myotonic Dystrophy Type 1
PHASE1/PHASE2
Recruiting
116 participants
Started: Sep 5, 2022 · Completed: Jul 31, 2029
1 condition
1 sponsor
9 locations
NCT04972656
Treatment With Ambrisentan in Patients With Borderline Pulmonary Arterial Hypertension
NA
Recruiting
420 participants
Started: Sep 5, 2022 · Completed: Mar 30, 2026
1 condition
2 sponsors
1 location
NCT05578196
Fecal Microbial Transplantation in Critically Ill Patients With Severe Infections.
NA
Recruiting
110 participants
Started: Sep 4, 2022 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT05555771
Paediatric Syncope in the Emergency Department
NA
Recruiting
300 participants
Started: Sep 3, 2022 · Completed: Sep 30, 2026
3 conditions
4 sponsors
1 location
NCT05543954
68Ga-FAPI-RGD PET/CT Imaging in the Lung Cancer Patients
EARLY_PHASE1
Recruiting
60 participants
Started: Sep 3, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05888038
Virtual Reality's Effect on Decreasing Pain and Subsequent Opioid Use in Pediatric Patients in the Post-Operative Period Following Scoliosis Repair
NA
Recruiting
50 participants
Started: Sep 3, 2022 · Completed: Sep 30, 2024
3 conditions
1 sponsor
1 location
NCT05303649
Effects of Neuronavigated Theta Burst Stimulation in Therapy of Post-stroke Aphasia
NA
Recruiting
45 participants
Started: Sep 2, 2022 · Completed: Dec 31, 2027
2 conditions
1 sponsor
1 location
NCT05464810
Letrozole With and Without Simvastatin for the Treatment of Stage I-III Hormone Receptor Positive, HER2 Negative Breast Cancer
EARLY_PHASE1
Recruiting
40 participants
Started: Sep 2, 2022 · Completed: Apr 15, 2027
6 conditions
2 sponsors
4 locations
NCT06794203
Hyperthyroidism as a Potential Predictive of Worse Outcome of Renal Graft
N/A
Recruiting
100 participants
Started: Sep 2, 2022 · Completed: Jul 1, 2025
3 conditions
1 sponsor
1 location
NCT05309655
Cardiac Outcomes With Near-Complete Estrogen Deprivation
NA
Recruiting
90 participants
Started: Sep 2, 2022 · Completed: Dec 31, 2027
3 conditions
3 sponsors
3 locations
NCT04872790
Venetoclax, Dasatinib, Prednisone, Rituximab and Blinatumomab for the Treatment of Newly Diagnosed or Relapsed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia or Mixed Phenotype Acute Leukemia
PHASE1
Recruiting
20 participants
Started: Sep 2, 2022 · Completed: Dec 31, 2026
5 conditions
3 sponsors
1 location
NCT05516537
Examining the Effects of a Remotely-delivered, Racially-tailored Exercise Training Program for Immediate and Sustained Improvements in Walking Dysfunction, Symptoms, and Health-related Quality of Life (HRQOL) Among African-Americans With Multiple Sclerosis (MS) Residing in Rural Environments.
NA
Recruiting
100 participants
Started: Sep 2, 2022 · Completed: Aug 31, 2026
1 condition
3 sponsors
1 location
NCT05377177
Cortical Inhibition as a Biomarker of Response in a Comparison of Bilateral Versus Unilateral Accelerated Theta Burst Stimulation for Suicidal Ideation in Treatment-Resistant Depression -COMBAT-SI
NA
Recruiting
76 participants
Started: Sep 2, 2022 · Completed: Jul 30, 2030
2 conditions
2 sponsors
1 location
NCT06098781
Gynaecological Gender-affirming Surgeries
N/A
Recruiting
57 participants
Started: Sep 2, 2022 · Completed: Jun 1, 2025
1 condition
1 sponsor
1 location
NCT05296317
Evaluation and Modeling of the Effect of G-CSF on the Evolution of Polynuclear Neutrophils During Dense Dose Epirubicin-Cyclophosphamide Regeneration
NA
Recruiting
100 participants
Started: Sep 2, 2022 · Completed: Oct 2, 2025
1 condition
1 sponsor
1 location
NCT05366166
Pembrolizumab Plus Olaparib in LA-HNSCC
PHASE2
Recruiting
45 participants
Started: Sep 2, 2022 · Completed: Oct 31, 2026
1 condition
2 sponsors
4 locations
NCT05717959
Efficacy of Oropharyngeal Exercises for Patients With Obstructive Sleep Apnea Using Mandibular Advancement Device
NA
Recruiting
20 participants
Started: Sep 2, 2022 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT05480982
Cognitive Functional Therapy Compared With Pilates in Elderly Patients With Chronic Low Back Pain
NA
Recruiting
200 participants
Started: Sep 2, 2022 · Completed: Sep 30, 2025
1 condition
1 sponsor
1 location
NCT05925218
Circulating Tumor DNA Collection From Patients With High Grade Gliomas
N/A
Recruiting
70 participants
Started: Sep 2, 2022 · Completed: Sep 30, 2027
1 condition
1 sponsor
1 location
NCT05214222
Penpulimab Plus Chemotherapy With/Without Anlotinib for Patients With Advanced Esophageal Squamous Cell Carcinoma
PHASE2
Recruiting
100 participants
Started: Sep 2, 2022 · Completed: Sep 2, 2028
1 condition
1 sponsor
1 location
NCT05366179
Autologous CAR-T Cells Targeting B7-H3 in Recurrent or Refractory GBM CAR.B7-H3Tc
PHASE1
Recruiting
36 participants
Started: Sep 2, 2022 · Completed: May 30, 2030
1 condition
1 sponsor
1 location
NCT06726850
Clinical Study to Evaluate the Efficacy and Safety of GS1-144 Tablets in the Treatment of Moderate to Severe Vasomotor Symptoms in Chinese Postmenopausal Women.
PHASE2
Recruiting
129 participants
Started: Sep 2, 2022 · Completed: Jun 30, 2025
1 condition
1 sponsor
1 location
NCT03810768
Metabolomics Study on Postoperative Intensive Care Acquired Muscle Weakness
N/A
Recruiting
20 participants
Started: Sep 2, 2022 · Completed: Dec 31, 2026
7 conditions
4 sponsors
3 locations
NCT05212272
MRI in High-Grade Glioma Patients Undergoing Chemoradiation
NA
Recruiting
16 participants
Started: Sep 2, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05824871
A Phase III Study of Oral Sudapyridine (WX-081) Tablets in Rifampicin-Resistant Pulmonary Tuberculosis Patients
PHASE3
Recruiting
450 participants
Started: Sep 2, 2022 · Completed: Oct 22, 2026
2 conditions
1 sponsor
2 locations
NCT03824106
Frailty Rehabilitation
NA
Recruiting
324 participants
Started: Sep 2, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT07024667
Clinical and Molecular Study to Evaluate the Effect of the Pixel CO2 Laser (FemiLiftTM) for the Treatment of Vulvo-Vaginal Atrophy
NA
Recruiting
20 participants
Started: Sep 2, 2022 · Completed: Dec 31, 2027
2 conditions
1 sponsor
1 location
NCT05339698
3D Evaluation to Quantify Regional Volume Change Between FRC and TLC
N/A
Recruiting
100 participants
Started: Sep 2, 2022 · Completed: Sep 30, 2024
1 condition
1 sponsor
1 location
NCT06267781
RRMS: Disease PROgression and Myeloid Profiling After Bone Marrow TRANSPLANTation and Second Line Therapies
N/A
Recruiting
30 participants
Started: Sep 2, 2022 · Completed: Sep 2, 2027
1 condition
1 sponsor
1 location
NCT05624658
Effect of Combined Lipid-lowering Therapy on Atherosclerotic Plaque Vulnerability in Patients With ACS
NA
Recruiting
200 participants
Started: Sep 2, 2022 · Completed: May 31, 2024
1 condition
2 sponsors
1 location
NCT05094570
Interleukin-4Ra Blockade by Dupilumab Decreases Staphylococcus Colonization and Increases Microbial Diversity in CRSwNP
PHASE4
Recruiting
20 participants
Started: Sep 1, 2022 · Completed: Dec 31, 2026
2 conditions
2 sponsors
1 location
NCT05151965
Return to Sport and Functional Performance Following Surgical Intervention for Anterior Glenohumeral Instability
N/A
Recruiting
72 participants
Started: Sep 1, 2022 · Completed: Apr 1, 2026
2 conditions
1 sponsor
1 location
NCT05270902
Haemoadsorption During Heart Transplantation
NA
Recruiting
40 participants
Started: Sep 1, 2022 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT05619068
The Evolution and Prognosis of Moyamoya Disease
N/A
Recruiting
300 participants
Started: Sep 1, 2022 · Completed: Dec 31, 2027
4 conditions
2 sponsors
1 location
NCT06677866
Group CBT in Adolescents With Fragile X Syndrome and in Adolescents With Autism Spectrum Disorder
NA
Recruiting
20 participants
Started: Sep 1, 2022 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT05515796
Multi-omics Sequencing in Neoadjuvant Immunotherapy of Gastrointestinal Tumors
PHASE2
Recruiting
200 participants
Started: Sep 1, 2022 · Completed: Dec 31, 2026
5 conditions
1 sponsor
1 location
NCT05968729
Assessment of Gait Adaptation Due to an Asymmetric Walking Protocol
NA
Recruiting
40 participants
Started: Sep 1, 2022 · Completed: Jul 31, 2027
1 condition
2 sponsors
1 location
NCT06163612
Effect of Suicidality on Social Cognition
N/A
Recruiting
150 participants
Started: Sep 1, 2022 · Completed: Dec 31, 2024
2 conditions
1 sponsor
1 location
NCT05317221
Developing Breast (Cancer) Organoids
N/A
Recruiting
60 participants
Started: Sep 1, 2022 · Completed: May 1, 2028
1 condition
3 sponsors
1 location
NCT05533892
Nocardia Rubra Cell Wall Skeleton (N-CWS) Plus HAIC, Lenvatinib and Tislelizumab in Treating Patients With Advanced HCC
PHASE1
Recruiting
30 participants
Started: Sep 1, 2022 · Completed: Feb 28, 2025
1 condition
10 sponsors
1 location
NCT06175416
Spontaneous Pneumothorax in Adolescents
N/A
Recruiting
134 participants
Started: Sep 1, 2022 · Completed: Dec 31, 2023
1 condition
1 sponsor
1 location
NCT05521022
Study of AT-02 in Healthy Volunteers and Subjects With Systemic Amyloidosis
PHASE1
Recruiting
100 participants
Started: Sep 1, 2022 · Completed: Mar 1, 2025
1 condition
2 sponsors
11 locations
NCT05432687
Impact of Abdominal Incompetence on Urinary Incontinence After Prostatectomy (PROSTABDO)
NA
Recruiting
80 participants
Started: Sep 1, 2022 · Completed: Oct 31, 2025
1 condition
1 sponsor
1 location
NCT05585255
Clinical Significance of DKK2 Protein in Cerebral Ischemia-reperfusion Injury
N/A
Recruiting
108 participants
Started: Sep 1, 2022 · Completed: Sep 30, 2024
3 conditions
1 sponsor
2 locations
Previous
1
More pages
942
943
944
945
946
947
948
More pages
1333
Next